相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefits of eculizumab in AQP4+neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Jacqueline Palace et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
James E. Frampton
DRUGS (2020)
Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis
Gerard Socie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Neuromyelitis optica spectrum disorders
Saif Huda et al.
CLINICAL MEDICINE (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow et al.
FRONTIERS IN NEUROLOGY (2018)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
Christoph Licht et al.
KIDNEY INTERNATIONAL (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao et al.
NEUROLOGY (2013)
Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation
J. Zuber et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
A secondary progressive clinical course is uncommon in neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2007)
The spectrum of neuromyelitis optica
Dean M. Wingerchuk et al.
LANCET NEUROLOGY (2007)
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
分享论文
